Robert E. Landry
CIK: 0001585160
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 15, 2026CYTK
CYTOKINETICS INC
Sale(S)Direct1K shares at avg. $72.13$72K - Sep 11, 2026CYTK
CYTOKINETICS INC
Sale(S)Direct1K shares at avg. $74.66$75K - May 27, 2026CYTK
CYTOKINETICS INC
Award(A)Direct2.9K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
Award(A)DirectStock Option (Right to Buy)
11.5K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
Award(A)DirectRestricted Stock Unit
7.7K shares- - Aug 11, 2025ZYME
Zymeworks Inc.
Award(A)DirectStock Option (Right to Buy)
62K shares- - May 14, 2025CYTK
CYTOKINETICS INC
Award(A)Direct7.3K shares- - Feb 10, 2025CYTK
CYTOKINETICS INC
Award(A)DirectNon-Qualified Stock Option (Right to Buy)
25.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  CYTK CYTOKINETICS INC | Sale(S) | 1,000 | $72.13 | $72,130 | Direct |
| Sep 11, 2026 | CYTK CYTOKINETICS INC | Sale(S) | 1,000 | $74.66 | $74,660 | Direct |
| May 27, 2026 | CYTK CYTOKINETICS INC | Award(A) | 2,851 | - | $0 | Direct |
| Jan 12, 2026 |  ZYME Zymeworks Inc. | Award(A) Stock Option (Right to Buy) | 11,500 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award(A) Restricted Stock Unit | 7,700 | - | - | Direct |
| Aug 11, 2025 | ZYME Zymeworks Inc. | Award(A) Stock Option (Right to Buy) | 62,000 | - | - | Direct |
| May 14, 2025 | CYTK CYTOKINETICS INC | Award(A) | 7,333 | - | - | Direct |
| Feb 10, 2025 | CYTK CYTOKINETICS INC | Award(A) Non-Qualified Stock Option (Right to Buy) | 25,538 | - | - | Direct |
1-8 of 8 transactions
About Landry Robert E
Landry Robert E (SEC CIK 0001585160) files insider reports with the SEC as Director of CYTOKINETICS INC (CYTK) and Director of Zymeworks Inc. (ZYME).
Signal8 holds 9 ownership filings by Landry Robert E (2 Form 3, 7 Form 4), filed between Feb 11, 2025 and Sep 15, 2026. Those filings report 8 transactions, from Feb 10, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Landry Robert E's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Landry Robert E
- Sep 15, 2026: Open-market sale of CYTK shares (Form 4, code S).
- Sep 11, 2026: Open-market sale of CYTK shares (Form 4, code S).
- May 27, 2026: Grant or award of CYTK shares (Form 4, code A).
- Jan 12, 2026: Grants or awards of ZYME derivative securities (2 lines, Form 4, code A).
- Aug 11, 2025: Grant or award of ZYME derivative securities (Form 4, code A).
Other insiders filing for CYTOKINETICS INC (CYTK)
- Blum Robert I, President & CEO
- Wysenski Nancy, Director
- Kaye Edward M. MD, Director
- Harrington Robert Arthur, Director
- Daly James M, Director
- WIERENGA WENDELL, Director